17 research outputs found

    Time-dependent evolution of the quantitative cluster maps.

    No full text
    <p>a) Alexa488-α-BTX labeled AChR particles imaged with TIRF microscopy in CHO-K1/A5 cells. The left column shows the interpolated cluster maps resulting from local-point pattern analysis of 4×4 µm regions in control and CDx-treated cells at the indicated intervals (10 min, 15 min). The maps, based on Ripley’s K-function <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone.0100346-Owen1" target="_blank">[39]</a> provide a graphical representation of the degree of aggregation of particles (black dots) per unit area in the entire series of frames. The threshold radius for assigning cluster status to a group of particles is set at 200 nm. The right column corresponds to the map of clustered BTX-stained particles, pseudocolored according to relative brightness of the detected particles. b) Time-dependent evolution of the cluster maps of mAb-crosslinked AChR particles. The left column corresponds to the interpolated cluster map based on Ripley’s K-function applied to CHO-K1/A5 cells labeled with primary anti-AChR monoclonal antibody (mAb210) followed by staining with Alexa<sup>488</sup>-labeled secondary antibody. The right column shows the map of clustered AChR particles pseudocolored according to brightness. Scale bar: 0.2 µm.</p

    Multiple trajectories of AChR particles labeled with BTX and mAb210, respectively.

    No full text
    <p>Sequence of 15 successive frames (out of a total of 1024) corresponding to control BTX- (left column) and mAb (right column)-labeled samples superimposed on the raw TIRF initial frames. Particles were initially localized using a fixed-width Gaussian fitting. Detected particles were subsequently analyzed for their trajectories with the software Localizer <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone.0100346-Dedecker1" target="_blank">[34]</a> ran in an Igor-Pro environment. Typical total number of trajectories was in the order of 800 (4%) and 700 (ca. 10%) out of a total of 15,000 and 8,000 for BTX and mAb-labeled samples, respectively. Scale bar = 3 µm.</p

    AChR particle mobility is drastically hindered by antibody crosslinking.

    No full text
    <p>a) Histogram depicting the distribution of diffusion coefficients for all trajectories for control fluorescent mAb-labeled samples (blue), and for samples treated with 10 mM CDx for 10 min (red), 20 min (green) and 40 min (purple), respectively. The shaded inset indicates the upper limit of the microscopic diffusion coefficient D<sub>2–4.</sub> One can clearly observe that the amount of particles with D<sub>2–4</sub> below the critical value is higher than in the case of the BTX-labeled samples (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone-0100346-g005" target="_blank">Figure 5a</a>). b) Histogram showing the proportion of different types of motion undergone by all trajectories (S-simple; D-directed; R-restricted or confined; U-undetermined). The color scale codes for control fluorescent mAb-labeled samples (blue), and samples treated with 10 mM CDx for 10 min (red), 20 min (green) and for 40 min (purple), respectively. c) Representative percentages of types of motion corresponding to the histograms in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone-0100346-g007" target="_blank">Figure 7b</a>.</p

    AChR particle and cluster statistics from the time-series experiments.

    No full text
    <p>The threshold radius for assigning cluster status to a group of particles was set at 200 nm.</p><p>Symbols denote statistically significant differences (Kruskal Wallis test, P<0.05).</p><p>Total number of particles:</p>b<p>exhibited statistically significant difference with a and c.</p>d<p>exhibited statistically significant difference with e, f and g.</p><p>Particles in clusters:</p>b<p>exhibited statistically significant difference with a and c.</p>d<p>exhibited statistically significant difference with e, f and g.</p><p>Brightness:</p>a<p>exhibited statistically significant difference with b and c.</p>e<p>exhibited statistically significant difference with d, f and g.</p

    MSDs of particle trajectories in fluorescent BTX-labeled samples.

    No full text
    <p>Raw traces and b) MSD vs. <i>Δt</i> for <i>all</i> trajectories having more than 15 frames, including outliers; b) zoom of (a) showing the 15 initial <i>Δt</i> intervals only. Both a and b are control fluorescent BTX-labeled samples, and c–d are the corresponding samples treated with 10 mM CDx. MSD is expressed in µm<sup>2</sup> and Δt in number of frames.</p

    MSDs of particle trajectories in mAb210 antibody-labeled samples.

    No full text
    <p>A) Raw traces and b) MSD vs. <i>Δt</i> for all trajectories having more than 15 frames, including outliers, as in Fig. 5; b) Zoom of (a) showing the 15 initial <i>Δt</i> intervals only. Both a and b correspond to the control fluorescent mAb-labeled samples, and c–d and e–f the corresponding samples treated with 10 mM CDx (20 and 40 min exposure, respectively). MSD is expressed in µm<sup>2</sup> and Δt in number of frames.</p

    Mobility parameters of AChR particles in samples labeled with Alexa<sup>488</sup>α-BTX or with a primary anti-AChR monoclonal antibody (mAb210) followed by staining with Alexa<sup>488</sup>-labeled secondary antibody, with or without treatment with 15 mM methyl-β-cyclodextrin (CDx).

    No full text
    <p>Mobility parameters of AChR particles in samples labeled with Alexa<sup>488</sup>α-BTX or with a primary anti-AChR monoclonal antibody (mAb210) followed by staining with Alexa<sup>488</sup>-labeled secondary antibody, with or without treatment with 15 mM methyl-β-cyclodextrin (CDx).</p

    Detection and visualization of individual particles in a fluorescence TIRF time-series.

    No full text
    <p>A) The three images correspond to the initial frames (1, 5 and 10, respectively) of a time-series obtained from a 7.2×7.2 µm region of a CHO-K1/A5 cell treated with 10 mM CDx for 20 min and labeled with Alexa<sup>488</sup>-αBTX. AChR particles labeled in blue correspond to those detected in the initial phase using the U-track method of Jaqaman et al. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone.0100346-Jaqaman1" target="_blank">[26]</a>. Pink-labeled pixels correspond to coincidences between initial estimation of a detected particle and the same, when validated upon optimization by application of the algorithms of Jaqaman et al. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone.0100346-Jaqaman1" target="_blank">[26]</a>. B) Visualization of the trajectories followed by several cell-surface AChR particles. The two upper figures correspond to CHO-K1/A5 cells labeled with a monovalent ligand (AlexaFluor<sup>488</sup>α-BTX, left) or BTX followed by CDx treatment. The two lower figures correspond to cells labeled with a multivalent ligand (monoclonal anti-AChR mAb210 antibody followed by AlexaFluor<sup>488</sup>-conjugated IgG secondary antibody) at 4°C and recorded as in Fig. 1. The different trajectories are color-coded to facilitate their identification and their temporal scale: initial (green), middle (blue) and final (red) portions of the trajectory are shown in each case. As a rule, particles were followed for periods of ∼25–40 s (300 initial steps at 12.4–7.5 Hz, 80–130 ms/frame). Notice the relative immobility of the mAb210 antibody-labeled samples in comparison to the α-BTX-labeled samples. Analyzed using the U-track method of Jaqaman et al. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone.0100346-Jaqaman1" target="_blank">[26]</a>.</p

    Individual trajectory and mean-squared displacement (MSD) of an AChR particle.

    No full text
    <p>The upper row shows the displacement of the same particle at the different time points indicated in the graph. The MSD (<i>t</i>) of the fluorescent-labeled particle was calculated for the initial 15 time lag intervals, Δ<i>t</i>, for trajectories longer than a critical number (15) of frames. In the example shown, the time-series was acquired at 20°C in a control CHO-K1/A5 cell labeled with Alexa<sup>488</sup>-α-BTX for 1 h at 4°C. The 2-dimensional MSD (<i>t</i>) for each particlés trajectory (Δ<i>r</i>(Δ<i>t</i>))<sup>2</sup>, was calculated for every time interval <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone.0100346-Kusumi1" target="_blank">[28]</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100346#pone.0100346-Qian1" target="_blank">[30]</a>.</p
    corecore